Pfizer is the latest pharma heavyweight to get behind the promise of gene therapy, as the New York drugmaker has laid out plans to set up a dedicated R&D operation and signed a deal with startup Spark Therapeutics to kick-start the effort.

…read more

Source: Pfizer buys into gene therapy’s renaissance and bets on Spark Therapeutics


0 No comments